We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCVI.WS
3326
CALL
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$98K ﹤0.01%
+9,995
New +$11.4K
VG
3327
DELISTED
Vonage Holdings Corporation
VG
$98K ﹤0.01%
+4,736
New +$86.3K
JOUT icon
3328
Johnson Outdoors
JOUT
$502M
$97K ﹤0.01%
1,038
-3,731
-78% -$392K
PTLO icon
3329
Portillo's
PTLO
$342M
$97K ﹤0.01%
+2,588
New +$104K
GSIT icon
3330
GSI Technology
GSIT
$214M
$96K ﹤0.01%
20,691
-3,155
-13% -$16.6K
MFG icon
3331
Mizuho Financial
MFG
$124B
$96K ﹤0.01%
+37,665
New +$99.4K
BTCS icon
3332
BTCS Inc
BTCS
$51.3M
$95K ﹤0.01%
+30,430
New +$181K
GAIA icon
3333
Gaia
GAIA
$48.6M
$95K ﹤0.01%
11,138
-59,097
-84% -$551K
MOH icon
3334
Molina Healthcare
MOH
$10.3B
$95K ﹤0.01%
300
-15,948
-98% -$4.74M
RJAC.U
3335
DELISTED
Jackson Acquisition Company Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
RJAC.U
$94K ﹤0.01%
+9,351
New +$93.3K
STKH
3336
Steakholder Foods
STKH
$775K
$93K ﹤0.01%
+15
New +$132K
WNEB icon
3337
Western New England Bancorp
WNEB
$295M
$93K ﹤0.01%
+10,729
New +$96.9K
WST icon
3338
West Pharmaceutical
WST
$23.8B
$93K ﹤0.01%
199
-248,900
-100% -$107M
SUNE
3339
SUNation Energy
SUNE
$8.7M
0
BPRN icon
3340
Princeton Bancorp
BPRN
$292M
$92K ﹤0.01%
+3,163
New +$94.7K
IBA
3341
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$92K ﹤0.01%
+2,152
New +$89.9K
GIACW
3342
CALL
DELISTED
Gesher I Acquisition Corp. Warrants
GIACW
$92K ﹤0.01%
+9,125
New +$5.4K
CNS icon
3343
Cohen & Steers
CNS
$4.24B
$91K ﹤0.01%
+976
New +$90.4K
LMB icon
3344
Limbach Holdings
LMB
$855M
$91K ﹤0.01%
+10,103
New +$74.1K
TRTN
3345
DELISTED
Triton International Limited
TRTN
$91K ﹤0.01%
1,503
-160,692
-99% -$9.36M
REXR icon
3346
Rexford Industrial Realty
REXR
$8.67B
$90K ﹤0.01%
1,108
-278,848
-100% -$19.3M
MSTR icon
3347
Strategy Inc
MSTR
$35.7B
$89K ﹤0.01%
+1,640
New +$113K
QIPT
3348
DELISTED
Quipt Home Medical
QIPT
$89K ﹤0.01%
+15,936
New +$93.1K
PLXP
3349
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$89K ﹤0.01%
11,084
-45,444
-80% -$533K
AKRO
3350
DELISTED
Akero Therapeutics
AKRO
$86K ﹤0.01%
+4,082
New +$90.5K

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.